Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nutra Pharma Corp. (NPHC)
OTHER OTC:NPHC
Nutra Pharma (NPHC) Stock Price & Analysis
18 Followers
NPHC Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Nutra Pharma News
PremiumCompany Announcements
Nutra Pharma Executives Exit Amid SEC Settlements
PremiumPress Releases
Nutra Pharma Corp. Reaches Settlement with SECOwnership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NPHC FAQ
What was Nutra Pharma Corp.’s price range in the past 12 months?
Currently, no data Available
What is Nutra Pharma Corp.’s market cap?
Currently, no data Available
When is Nutra Pharma Corp.’s upcoming earnings report date?
Nutra Pharma Corp.’s upcoming earnings report date is May 21, 2018 which is 2250 days ago.
How were Nutra Pharma Corp.’s earnings last quarter?
Currently, no data Available
Is Nutra Pharma Corp. overvalued?
According to Wall Street analysts Nutra Pharma Corp.’s price is currently Overvalued.
Does Nutra Pharma Corp. pay dividends?
Nutra Pharma Corp. does not currently pay dividends.
What is Nutra Pharma Corp.’s EPS estimate?
Nutra Pharma Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nutra Pharma Corp. have?
Nutra Pharma Corp. has 7,596,852,000 shares outstanding.
What happened to Nutra Pharma Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nutra Pharma Corp.?
Currently, no hedge funds are holding shares in NPHC
---
Company Description
Nutra Pharma Corp.
Nutra Pharma Corp. is a biopharmaceutical company, which is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies & homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Coral Springs, FL.
---
Arca Biopharma
―
Brainstorm Cell Therapeutics
―
Aethlon Medical
―
Eton Pharmaceuticals
―
---